Verrica Pharmaceuticals's total assets for Q3 2025 were $40.90M, an increase of 4.57% from the previous quarter. VRCA total liabilities were $57.94M for the fiscal quarter, a 2.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.